|
[Related PubMed/MEDLINE]
Total Number of Papers: 23
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
COVID-19 site readiness initiative: Building clinical trial capacity for vaccine efficacy trials in Latin America in response to the pandemic. |
COVID-19, SOP |
| 2 |
2022 |
Using structural equation modeling to examine the influence of family planning social norms on modern contraceptive use in Nigeria. |
FP, NURHI |
| 3 |
2021 |
Improving primary health care delivery in Bihar, India: Learning from piloting and statewide scale-up of Ananya. |
GoB, RMNCHN, SHGs |
| 4 |
2021 |
Joint study led by International Food Policy Research Institute (IFPRI) puts meat-eating women's lives at risk. |
FHI, IFPRI, JH |
| 5 |
2021 |
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. |
LiST |
| 6 |
2020 |
History of global burden of disease assessment at the World Health Organization. |
GBD, IHME |
| 7 |
2020 |
How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making. |
NIPs, TSE |
| 8 |
2020 |
Public-private partnering as a modus operandi: Explaining the Gates Foundation's approach to global health governance. |
LIC, PPPs |
| 9 |
2019 |
Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market. |
Gavi, WHO |
| 10 |
2019 |
Strengthening integration of family planning with HIV/AIDS and other services: experience from three Kenyan cities. |
FP, HTC |
| 11 |
2016 |
A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg. |
CI, HRP, LNG, RHR, WY |
| 12 |
2015 |
Deconstructing the differences: a comparison of GBD 2010 and CHERG's approach to estimating the mortality burden of diarrhea, pneumonia, and their etiologies. |
CHERG, GBD, IHME, WHO |
| 13 |
2015 |
From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project. |
CDC, EVA, MVP, WHO |
| 14 |
2015 |
Methodological variation in economic evaluations conducted in low- and middle-income countries: information for reference case development. |
--- |
| 15 |
2015 |
Path to impact: A report from the Bill and Melinda Gates Foundation convening on maternal immunization in resource-limited settings; Berlin - January 29-30, 2015. |
MI, MNCH |
| 16 |
2014 |
Annual World Vaccine Congress 2014: a re-evaluation of the value proposition for increasing vaccine thermostability. |
--- |
| 17 |
2014 |
The costs of scaling up HIV prevention for high risk groups: lessons learned from the Avahan Programme in India. |
NGOs, SLPs, STI |
| 18 |
2013 |
Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors. |
APC, ASRs, HPV |
| 19 |
2012 |
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. |
FINOVI, PAF |
| 20 |
2012 |
Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies. |
NIAID |
| 21 |
2011 |
Social sciences research in neglected tropical diseases 3: Investment in social science research in neglected diseases of poverty: a case study of Bill and Melinda Gates Foundation. |
NTD |
| 22 |
2010 |
Implications of HIV PrEP trials results. |
CDC, DAIDS, FDA, NIAID, NIH, PrEP, PrEP, TDF, USAID |
| 23 |
2008 |
Misfinancing global health: a case for transparency in disbursements and decision making. |
--- |
|
A Search Service for Abbreviation / Long Form
